Invention Grant
- Patent Title: Method of stimulating TLR9-activated immune response
-
Application No.: US15859022Application Date: 2017-12-29
-
Publication No.: US10337017B2Publication Date: 2019-07-02
- Inventor: Tsung-Hsien Chuang , Chao-Yang Lai
- Applicant: NATIONAL HEALTH RESEARCH INSTITUTES
- Applicant Address: TW Miaoli County
- Assignee: National Health Research Institutes
- Current Assignee: National Health Research Institutes
- Current Assignee Address: TW Miaoli County
- Agency: Muncy, Geissler, Olds & Lowe, P.C.
- Main IPC: A61K31/715
- IPC: A61K31/715 ; C12N15/117 ; A61K39/39 ; A01K67/00 ; A61K39/00

Abstract:
A method of stimulating a TLR9-activated immune response or enhancing a TLR9-activated immune response to an antigen is disclosed herein. TLR9 is the cellular receptor for CpG-ODN, and current developed CpG-ODN has low activity to rabbit TLR9. Here, the method of stimulating TLR9-activated immune response by administering an effective amount of immunogenic composition comprising an antigen and a CpG-ODN comprising GACGTT or AACGTT motif was demonstrated to have potent immunostimulatory activity to rabbit TLR9, and capable of boosting a less toxic and potent antibody response in rabbits.
Public/Granted literature
- US20180135053A1 METHOD OF STIMULATING TLR9-ACTIVATED IMMUNE RESPONSE Public/Granted day:2018-05-17
Information query